New paradigms in treatment of venous thromboembolism
Abstract
No abstract
References
1. Pinjala RENDORSE-India investigators. Venous thromboembolism risk and prophylaxis in acute hospital care setting. a multinational cross sectional study : results from the Indian subset data. Indian J Med Res 2012;136:60-7
2. Raskob GE, Angchalsuksiri P, Blanco AN, Buller H, GallusA, Hunt BJ et al Thrombosis a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014;34:2363-71
3. Cohen AT. Tapson VF,Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B et al Venous thromboembolism risk and prophylaxis an the acute hospital care setting( ENDORSE study): a multinational cross sectional study Lancet 2008;371:387-94
4. Schulman S, Lindmarker P, HO lmstrom M, Larfars G, Carlsson A, NicolP et al. Post thrombotic syndrome,recurrence and death 10 years after the first episode of venous thrombo embolism treated with warfarin for six weeks or six months J ThrombHaemost 2006;4:734-42
5. Kakkar N, Kaur R, John M Outpatient oral anticoagulant management –an audit of 82 patients J Assoc Physicians India 2005;53:847-52
6. Kakkar N, Kaur R Knowledge base of clinicians regarding oral anticoagulation therapy in teaching institution –a questionnaire survey J Assoc Physicians India 2004;52:868-72
7. Yeh CH, Gross PL, Weitz JL Evolving use of new oral anticoagulantsfor treatment of venous thromboembolism Blood 2014;124(7):1020-28
8. Moll S New insights into treatment of venous thromboembolism Hematology 2014;297-305
9. Waldron B,Moll S A patients guideto recovery after deep vein thrombosis or pulmonary embolism Circulation 2014;129(17):e 477-e479
10. Wells PS,Forgie MA,Rodger MA Treatment of venous thromboembolism JAMA 2014;311(7):717-28
11. CohenAT,ImfeldS,Rider T Phase III trials of new oral anticoagulants i the acute treatment and secondary prevention of VTE:comparison and critique of study methodology and results Adv Ther 2014;31(5): 473-93
12. Cushman M, Lim W, Zakai NA Clinical practice guide on anti thrombotic drug dosing and management of antithrombotic drug associated bleeding complications in adults http://www.hematology.org/ clinicians/guidelines-Quality/Quick-Ref/2869.aspx. September 14,2014
13. Pollack CV, Relly PA, Elkelboom J, et al Idarucizumab for dabigatran reversal N Engl J Med 2015;373:511-20
14. Kearan C, Omelas J, Blairas DO Anti thrombotic therapy for VTE disease Chest guidelines and expert panel report Chest 2016;149:315-52
15. Simes J, Becanttini C, Agnelli G et al Aspirin for prevention of recurrent venous thromboembolism : the INSPIRE collaboration Circulation 2014;130(130:1062- 71
16. Mantha S, Karp R,Raghvan V et al Assessing the risk of venous thromboembolic events in women taking progestinonly cpntraception – a meta analysis BMJ 2012;345:e4944
17. Kahn SR, Shapiro S,Wells PS et al Compression stockings to prevent post thrombotic syndrome a randomised placebo controlled trial Lancet 2014; 383(9920):880-88
2. Raskob GE, Angchalsuksiri P, Blanco AN, Buller H, GallusA, Hunt BJ et al Thrombosis a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014;34:2363-71
3. Cohen AT. Tapson VF,Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B et al Venous thromboembolism risk and prophylaxis an the acute hospital care setting( ENDORSE study): a multinational cross sectional study Lancet 2008;371:387-94
4. Schulman S, Lindmarker P, HO lmstrom M, Larfars G, Carlsson A, NicolP et al. Post thrombotic syndrome,recurrence and death 10 years after the first episode of venous thrombo embolism treated with warfarin for six weeks or six months J ThrombHaemost 2006;4:734-42
5. Kakkar N, Kaur R, John M Outpatient oral anticoagulant management –an audit of 82 patients J Assoc Physicians India 2005;53:847-52
6. Kakkar N, Kaur R Knowledge base of clinicians regarding oral anticoagulation therapy in teaching institution –a questionnaire survey J Assoc Physicians India 2004;52:868-72
7. Yeh CH, Gross PL, Weitz JL Evolving use of new oral anticoagulantsfor treatment of venous thromboembolism Blood 2014;124(7):1020-28
8. Moll S New insights into treatment of venous thromboembolism Hematology 2014;297-305
9. Waldron B,Moll S A patients guideto recovery after deep vein thrombosis or pulmonary embolism Circulation 2014;129(17):e 477-e479
10. Wells PS,Forgie MA,Rodger MA Treatment of venous thromboembolism JAMA 2014;311(7):717-28
11. CohenAT,ImfeldS,Rider T Phase III trials of new oral anticoagulants i the acute treatment and secondary prevention of VTE:comparison and critique of study methodology and results Adv Ther 2014;31(5): 473-93
12. Cushman M, Lim W, Zakai NA Clinical practice guide on anti thrombotic drug dosing and management of antithrombotic drug associated bleeding complications in adults http://www.hematology.org/ clinicians/guidelines-Quality/Quick-Ref/2869.aspx. September 14,2014
13. Pollack CV, Relly PA, Elkelboom J, et al Idarucizumab for dabigatran reversal N Engl J Med 2015;373:511-20
14. Kearan C, Omelas J, Blairas DO Anti thrombotic therapy for VTE disease Chest guidelines and expert panel report Chest 2016;149:315-52
15. Simes J, Becanttini C, Agnelli G et al Aspirin for prevention of recurrent venous thromboembolism : the INSPIRE collaboration Circulation 2014;130(130:1062- 71
16. Mantha S, Karp R,Raghvan V et al Assessing the risk of venous thromboembolic events in women taking progestinonly cpntraception – a meta analysis BMJ 2012;345:e4944
17. Kahn SR, Shapiro S,Wells PS et al Compression stockings to prevent post thrombotic syndrome a randomised placebo controlled trial Lancet 2014; 383(9920):880-88
Published
2019-07-08
How to Cite
Sunil Bichile. (2019). New paradigms in treatment of venous thromboembolism. The Indian Practitioner, 69(12), 7-8. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/339
Section
Editorial
